Home - Products - Others - Other Targets - N-Methyl-4-pyridone-3-carboxamide

N-Methyl-4-pyridone-3-carboxamide

CAS No. 769-49-3

N-Methyl-4-pyridone-3-carboxamide( —— )

Catalog No. M37955 CAS No. 769-49-3

N-Methyl-4-pyridone-3-carboxamide is a metabolite of coffee pyridines.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 549 In Stock
10MG 820 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    N-Methyl-4-pyridone-3-carboxamide
  • Note
    Research use only, not for human use.
  • Brief Description
    N-Methyl-4-pyridone-3-carboxamide is a metabolite of coffee pyridines.
  • Description
    N-Methyl-4-pyridone-3-carboxamide is a metabolite of coffee pyridines.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Other Targets
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    769-49-3
  • Formula Weight
    152.15
  • Molecular Formula
    C7H8N2O2
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO : 50 mg/mL (328.62 mM)
  • SMILES
    O=C(C1=CN(C)C=CC1=O)N
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Bresciani L, et al. Absorption, Pharmacokinetics, and Urinary Excretion of Pyridines After Consumption of Coffee and Cocoa-Based Products Containing Coffee in a Repeated Dose, Crossover Human Intervention Study. Mol Nutr Food Res. 2020 Sep;64(18):e2000489.
molnova catalog
related products
  • 6'-Hydroxy-3,4,2',3'...

    6'-Hydroxy-3,4,2',3',4'-pentamethoxychalcone is an alkenylphenol from Piper obliquum with antiinflammatory and antibacterial activities.

  • cis-2-Hydroxy 4-meth...

    The herbs of Acanthopanax gracilistylus.

  • 6-Acryloyloxyhexyl p...

    6-Acryloyloxyhexyl phosphater (PA21) is a novel phosphate-binding agent, which is an iron-based reagent, and can be used for the treatment of hyperphosphatemia in chronic kidney disease.